Editas Medicine, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Editas Medicine, Inc. on April 7, 2026, covering events occurring on April 1, 2026. The filing addresses a change in the Company's independent registered public accounting firm.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance regarding the audit firm.
Material Changes
- Dismissal of Auditor: The Audit Committee dismissed Ernst & Young LLP as the independent registered public accounting firm, effective immediately on April 1, 2026.
- Appointment of New Auditor: PricewaterhouseCoopers LLP (PwC) was appointed as the new independent registered public accounting firm for the fiscal year ending December 31, 2026.
- Audit History: Reports by Ernst & Young for fiscal years ended December 31, 2024, and December 31, 2025, contained no adverse opinions, disclaimers, or qualifications.
- Disagreements: There were no disagreements or reportable events between the Company and Ernst & Young during the relevant periods.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, outlook, or management commentary on business operations. The decision to change auditors was made after soliciting proposals and conducting a formal review. The Company has requested a letter from Ernst & Young regarding their agreement with the disclosure, which is filed as Exhibit 16.1.
Investor Verification Checklist
- Review Exhibit 16.1 (Letter from Ernst & Young LLP) to confirm the former auditor agrees with the Company's disclosure regarding the dismissal.
- Verify the transition timeline and scope of work for PwC for the fiscal year ending December 31, 2026.
- Monitor upcoming financial filings (10-K/10-Q) for any restatements or changes in accounting principles resulting from the auditor change.